GENSIGHT BIOLOGICS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4195 EUR | +0.36% |
|
+2.32% | -8.80% |
| 04-05 | GenSight: financial visibility assured until the end of April | CF |
| 03-25 | GenSight: share price falls, limited financial visibility | CF |
Chart calendar GenSight Biologics S.A.
72631eccee9.CgAUIrxpa7bYF2Ej6KvCFBniKkOISuqZvkHfJIRR3Mg.fU5sFJEtMu7hR1Bvmu-nf1iaHTO5EIPB8DeZV7MDkK94ZHhP0iha_opYIA~9ab03eb23b143063335d54351963d90a
Upcoming events on GenSight Biologics S.A.
Past events on GenSight Biologics S.A.
| 04/04/2024 20:12 | Q1 2024 Sales and Revenue Release |
| 22/03/2024 17:00 | Q4 2023 Earnings Release |
| 24/01/2024 | Q4 2023 Sales and Revenue Release |
| 26/10/2023 17:00 | Q3 2023 Sales and Revenue Release |
| 25/07/2023 | Q2 2023 Earnings Release |
| 20/06/2023 | Annual General Meeting |
| 26/04/2023 16:30 | Association for Research in Vision and Ophthalmology Meeting - Alfredo A. Sadun |
| 24/04/2023 22:15 | Association for Research in Vision and Ophthalmology Meeting - Chiara La Morgia |
| 24/04/2023 22:00 | Association for Research in Vision and Ophthalmology Meeting - Patrick Yu-Wai-Man |
| 24/04/2023 17:03 | American Academy of Neurology Meeting - Valérie Biousse |
| 24/04/2023 16:51 | American Academy of Neurology Meeting - Nancy J. Newman |
| 20/04/2023 15:30 | Business Update Call |
| 19/04/2023 | Q1 2023 Sales and Revenue Release |
| 05/04/2023 13:00 | Business Update Call |
| 24/03/2023 06:30 | Q4 2022 Earnings Release |
| 14/03/2023 22:30 | North American Neuro-Ophthalmology Society Meeting - Poster No: 279 |
| 14/03/2023 22:00 | North American Neuro Ophthalmology Society Meeting - Mark L. Moster |
| 14/03/2023 22:00 | North American Neuro Ophthalmology Society Meeting - Patrick Yu-Wai-Man |
| 14/03/2023 22:00 | North American Neuro Ophthalmology Society Meeting - Catherine Vignal |
| 14/03/2023 22:00 | North American Neuro Ophthalmology Society Meeting - Alfredo A. Sadun |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 4,90 7,10 -30.99% | 7,40 9,33 -20.71% | 7,70 12,5 -38.24% | 4,90 4,30 13.95% | 3,00 2,20 36.36% | 4,40 |
|
EBITDA Million EUR | Released Forecast Spread | -29,3 -27,5 -6.42% | -24,0 -18,0 -33.27% | -27,2 -23,0 -18.51% | -26,8 -36,7 27.05% | -27,5 -26,1 -5.43% | -25,1 |
|
EBIT Million EUR | Released Forecast Spread | -30,3 -27,7 -9.4% | -24,9 -18,4 -35.55% | -28,1 -22,1 -27.15% | -27,8 -37,6 26.06% | -29,7 -27,2 -9.19% | -26,2 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -30,7 -29,4 -4.45% | -34,0 -18,9 -79.73% | -28,6 -23,2 -23.61% | -27,6 -33,4 17.31% | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -30,7 -27,7 -10.65% | -34,0 -18,9 -79.66% | -28,6 -23,4 -22.22% | -27,6 -36,7 24.69% | -26,2 -26,3 0.38% | -26,0 |
|
EPS EUR | Released Forecast Spread | -1,08 -0,96 -11.94% | -0,97 -0,53 -81.88% | -0,63 -0,50 -26% | -0,60 -0,80 25% | -0,54 -0,58 6.9% | -0,57 |
| Announcement Date | 12/03/20 | 10/03/21 | 08/04/22 | 24/03/23 | 22/03/24 | - |
More events
Past sector events for GenSight Biologics S.A.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SIGHT Stock
- Calendar GenSight Biologics S.A.
